Agenus to provide corporate update and fourth quarter & full year 2023 financial report

Lexington, mass.--(business wire)--agenus inc. (“agenus”) (nasdaq: agen), a leader in discovering and developing novel immunological agents to treat various cancers, today announced that the company will release its fourth quarter and year end 2023 financial results before the market opens on thursday, march 14, 2024. agenus executives will host a conference call and webcast at 8:30 a.m. et that morning to discuss the results and provide a corporate update. conference call: to access dial-in nu.
AGEN Ratings Summary
AGEN Quant Ranking